Sartani G - Search Results

1

Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial.

Avni I, Garzozi HJ, Barequet IS, Segev F, Varssano D, Sartani G, Chetrit N, Bakshi E, Zadok D, Tomkins O, Litvin G, Jacobson KA, Fishman S, Harpaz Z, Farbstein M, Yehuda SB, Silverman MH, Kerns WD, Bristol DR, Cohn I, Fishman P. Avni I, et al. Among authors: sartani g. Ophthalmology. 2010 Jul;117(7):1287-93. doi: 10.1016/j.ophtha.2009.11.029. Epub 2010 Mar 20. Ophthalmology. 2010. PMID: 20304499 Free PMC article. Clinical Trial.

2

Reactivation of ocular toxoplasmosis after LASIK.

Barbara A, Shehadeh-Masha'our R, Sartani G, Garzozi HJ. Barbara A, et al. Among authors: sartani g. J Refract Surg. 2005 Nov-Dec;21(6):759-61. doi: 10.3928/1081-597X-20051101-18. J Refract Surg. 2005. PMID: 16329371

3

Cat-scratch disease: ocular manifestations and treatment outcome.

Habot-Wilner Z, Trivizki O, Goldstein M, Kesler A, Shulman S, Horowitz J, Amer R, David R, Ben-Arie-Weintrob Y, Bakshi E, Almog Y, Sartani G, Vishnevskia-Dai V, Kramer M, Bar A, Kehat R, Ephros M, Giladi M. Habot-Wilner Z, et al. Among authors: sartani g. Acta Ophthalmol. 2018 Jun;96(4):e524-e532. doi: 10.1111/aos.13684. Epub 2018 Mar 5. Acta Ophthalmol. 2018. PMID: 29504674 Free article.

4

Hypothalamic-pituitary-adrenal axis function following intravitreal triamcinolone acetonide injection.

Amiran MD, Yeung SN, Lang Y, Sartani G, Ishay A, Luboshitzky R. Amiran MD, et al. Among authors: sartani g. Int Ophthalmol. 2013 Apr;33(2):211-6. doi: 10.1007/s10792-012-9659-5. Epub 2012 Nov 7. Int Ophthalmol. 2013. PMID: 23132214 Clinical Trial.

5

Seroprevalence of antibodies against Toxoplasma gondii among two rural populations in northern Israel.

Raz R, Nishri Z, Mates A, Sartani G, Hadad N, Reichman N, Miron D, Flatau E. Raz R, et al. Among authors: sartani g. Isr J Med Sci. 1993 Oct;29(10):636-9. Isr J Med Sci. 1993. PMID: 8244662

6

Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.

Sartani G, Silver PB, Rizzo LV, Chan CC, Wiggert B, Mastorakos G, Caspi RR. Sartani G, et al. Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2211-8. Invest Ophthalmol Vis Sci. 1996. PMID: 8843907

7

Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents.

Mastorakos G, Bouzas EA, Silver PB, Sartani G, Friedman TC, Chan CC, Caspi RR, Chrousos GP. Mastorakos G, et al. Among authors: sartani g. Endocrinology. 1995 Oct;136(10):4650-8. doi: 10.1210/endo.136.10.7664685. Endocrinology. 1995. PMID: 7664685

8

Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.

Sartani G, Silver PB, Strassmann G, Chan CC, Caspi RR. Sartani G, et al. Curr Eye Res. 1995 Oct;14(10):887-96. doi: 10.3109/02713689508995128. Curr Eye Res. 1995. PMID: 8549154

9

T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.

Prendergast RA, Iliff CE, Coskuncan NM, Caspi RR, Sartani G, Tarrant TK, Lutty GA, McLeod DS. Prendergast RA, et al. Among authors: sartani g. Invest Ophthalmol Vis Sci. 1998 Apr;39(5):754-62. Invest Ophthalmol Vis Sci. 1998. PMID: 9538882

10

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.

Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM; Ozurdex MEAD Study Group. Boyer DS, et al. Ophthalmology. 2014 Oct;121(10):1904-14. doi: 10.1016/j.ophtha.2014.04.024. Epub 2014 Jun 4. Ophthalmology. 2014. PMID: 24907062 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters